Utomilumab Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden

Utomilumab is a fully human IgG2 monoclonal antibody with agonist activity at the tumour necrosis factor (TNF) receptor, 4-1BB (TNFRSF9), being investigated for potential clinical anti-tumour activity.

Utomilumab Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

Utomilumab Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
Biolab Reagents	027-65279366 18108604356	products@biolabreagent.com	China	9818	58
ShangHai Biochempartner Co.,Ltd	17754423994 17754423994	2853530910@QQ.com	China	8011	62
Guangzhou Hongyuan Chemical Co.,Ltd	15817493340	981810490@qq.com	China	1566	58
Wuhan Chemstan Biotechnology Co., Ltd.	027-65317797 15926423062	422450190@qq.com	China	10357	58
TargetMol Chemicals Inc.	4008200310	marketing@tsbiochem.com	China	24644	58
Wuhan Jingkangen Biomedical Technology Co., Ltd	13720134139 086-15871494362 13720134139	orders@jknbiochem.com	China	5907	58
Shanghai Yifei Biotechnology Co. , Ltd.	021-65675885 18964387627	customer_service@efebio.com	China	11974	58
Shanghai jerryxing Biomedical Technology Co., Ltd	17721492509	643638326@qq.com	China	4955	58
Changsha Fuzhen Biotechnology Co.，LTD	13823398779 18670069958	3062105966@qq.com	China	3343	58
Olix (Shanghai) Pharmaceutical Technology Co., Ltd	17316404525	209533805@qq.com	China	9970	58

---

• Utomilumab
• Research Grade Utomilumab (DHG11001)
• PF 05082566|||PF-2566
• Research Grade Utomilumab
• 1417318-27-4